Dina Baier
Impact in
-
- Sexual function and dysfunction studies
Papers in
-
- RNA modifications and cancer 4
-
- Treatment of Major Depression 6
- Pharmaceutical industry and healthcare 2
- Co-authors
- Walter Berger (17 shared papers)Michael Philipp (5 shared papers)Bernhard K. Keppler (9 shared papers)R. Kohnen (5 shared papers)Samuel M. Meier (6 shared papers)Thomas Mohr (5 shared papers)J. W. G. Tiller (2 shared papers)Christine Pirker (9 shared papers)
- Journals
- Pharmacopsychiatry (4 papers)Pharmaceutics (2 papers)Angewandte Chemie International Edition (2 papers)Cancers (2 papers)European Neuropsychopharmacology (2 papers)
- Partner nations
- AustriaGermanySwitzerland
In The Last Decade
Dina Baier
26 papers receiving 340 citations
Peers
Comparison fields: 5 of 80
- Psychiatry and Mental health 73
- Biological Psychiatry 12
- Oncology 104
- Organic Chemistry 93
- Toxicology 9
Countries citing papers authored by Dina Baier
This map shows the geographic impact of Dina Baier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Baier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Baier more than expected).
Fields of papers citing papers by Dina Baier
This network shows the impact of papers produced by Dina Baier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Baier. The network helps show where Dina Baier may publish in the future.
Co-authors
The 25 scholars most cited alongside Dina Baier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 52 | |
| 2 | 2000 | 31 | |
| 3 | 2019 | 26 | |
| 4 | 2022 | 26 | |
| 5 | 2020 | 25 | |
| 6 | 2016 | 22 | |
| 7 | 2020 | 20 | |
| 8 | 2023 | 16 | |
| 9 | 1994 | 16 | |
| 10 | 2023 | 16 | |
| 11 | 2018 | 15 | |
| 12 | 1997 | 14 | |
| 13 | 2021 | 13 | |
| 14 | [Guidelines for carrying out application studies in psychopharmacotherapy. "Phase IV Research" Study Group of the Society of Neuropsychopharmacology and Pharmacopsychiatry]. | 1994 | 13 |
| 15 | 1999 | 8 | |
| 16 | 1999 | 8 | |
| 17 | 2022 | 7 | |
| 18 | 2021 | 7 | |
| 19 | 2020 | 5 | |
| 20 | 1997 | 5 |
About Dina Baier
Dina Baier is a scholar working on Molecular Biology, Pharmacology, Psychiatry and Mental health, Oncology and Organic Chemistry, having authored 28 papers that have together received 358 indexed citations. Recurring topics across this work include Treatment of Major Depression (6 papers), RNA modifications and cancer (4 papers), Sexual function and dysfunction studies (3 papers), Cancer, Lipids, and Metabolism (2 papers), Tryptophan and brain disorders (2 papers), Pharmaceutical industry and healthcare (2 papers), Carbon dioxide utilization in catalysis (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Psychiatry and Mental health (73 citations), Biological Psychiatry (12 citations), Oncology (104 citations), Organic Chemistry (93 citations) and Toxicology (9 citations). Dina Baier has collaborated with scholars based in Austria, Germany and Switzerland. Frequent co-authors include Walter Berger, Michael Philipp, Bernhard K. Keppler, R. Kohnen, Samuel M. Meier, Thomas Mohr, J. W. G. Tiller, Christine Pirker, Gunda Koellensperger and Alessio Terenzi. Their work appears in journals such as Pharmacopsychiatry, Pharmaceutics, Angewandte Chemie International Edition, Cancers and European Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.